Advertisement
News
Advertisement

Ligon Discovery collaborates with Bayer Schering

Wed, 09/29/2010 - 11:37am
Mass High Tech: The Journal of New England Technology

Cambridge-based Ligon Discovery today announced a partnership with Bayer Schering Pharma AG of Germany to use Ligon’s Small Molecule Microarray (SMM) screening platform to seek drug candidates for new disease targets.

Ligon said in a press release that its SMM technology offers a new approach to identifying valid drug leads for historically intractable disease targets.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading